Results 241 to 250 of about 600,025 (282)
Some of the next articles are maybe not open access.

HYPOPHYSEO-ADRENAL FUNCTION IN DIABETIC ANGIOPATHY

Acta Endocrinologica, 1964
ABSTRACT It has been demonstrated that alterations in the corticotrophin-glucocorticoid system follow the extreme changes in carbohydrate metabolism which occur in diabetic patients. In acidosis and hypoglycaemia there is a transitory pathological increase in the plasma cortisol level and in the urinary 17-OHCS excretion.
S. Szücs, G. Csapó
openaire   +3 more sources

Gliclazide and Diabetic Angiopathy [PDF]

open access: possible, 2003
Vascular disease remains the major contributor to morbidity and mortality in the diabetic population. Conventional classification into micro- and macrovascular disease is a useful distinction for the purposes of research and debate, although several risk factors and mechanisms appear to be implicated in both patterns of disease.
openaire   +1 more source

Diabetic angiopathy: Tracking down the culprits

Journal of Diabetes and its Complications, 1996
espite the considerable morbidity and excess mortality attributable to diabetic angiopathy, it is a sobering fact that the physician possesses few therapeutic weapons with which to combat the condition. The clear exception is of course glycemic control and the publication of the Diabetes Control and Complication Trial has established that intensive ...
Angela C. Shore   +3 more
openaire   +3 more sources

Growth Hormone and Diabetic Angiopathy

1973
Publisher Summary This chapter describes the growth hormone and diabetic angiopathy. The most impressive way to demonstrate the abnormality of growth hormone production in diabetes is simply to observe the 24-hour pattern of plasma growth hormone in young male diabetics and nondiabetics of similar age during normal daily life.
openaire   +4 more sources

Pathophysiological mechanisms of diabetic angiopathy

Journal of Diabetes and its Complications, 2003
The sequelae of chronic hyperglycemia in diabetes of all phenotypes are divided into microvascular and macrovascular complications. Microvascular disease causes blindness, renal failure, and neuropathy, and diabetes-accelerated macrovascular disease causes excessive risk for myocardial infarction, stroke, and lower limb amputation.
openaire   +3 more sources

PAS-bisulfite stain for diabetic angiopathy

Beiträge zur Pathologie, 1974
Summary A modification of the PAS staining method is presented which aims to increase its specificity for diabetic angiopathy. The method is based on the Casella and Bauer technic of reduction of free aldehydes in the tissue by sodium bisulfite, thus a pale background is obtained and positive blood vessels stand out prominently.
Sohar E, Mordechai Ravid, Igal Kedar
openaire   +3 more sources

Angiopathy of Retinal Vessels in Diabetic Mice

Archives of Ophthalmology, 1970
An inbred line of Japanese mice established in 1957 and named the "KK Strain" has been studied for many attributes of its congenital diabetes. This study documents the occurrence of angiopathy in the retinal vessels and contrasts these findings to a similar sized and aged control group of nondiabetic Swiss Webster mice.
openaire   +3 more sources

Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.

Acta Haematologica, 1986
Since intravascular and endoparietal fibrin deposition is thought to be involved in the development of atherosclerosis, we measured factor XIII activity and its subunit 'a' and 'b' concentrations against a background of other haemostasis parameters in ...
J. Kłoczko   +4 more
semanticscholar   +1 more source

Angiopathy in children with diabetes.

Minerva pediatrica, 2002
Diabetic angiopathy includes those complications associated with chronic hyperglycaemia. The major long-term complications of diabetes can be categorized into two classes: macrovascular (i.e., cardiovascular complications) and microvascular (i.e., nephropathy, retinopathy, and neuropathy).
CHIARELLI, Francesco   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy